Stock Analiz

Nuvectis Pharma, Inc. (NVCT) stock forecast and price target

Price $20.24 · data as of November 13, 2026

12-month price target

Average target$35.40
Upside / downside+74.9%
Analysts5
ConsensusStrong buy
Low $30.00Average $35.40High $40.00

Gold marker: average target · white marker: today’s price ($20.24)

Analyst ratings

Strong buy 2Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.03—$0
Next fiscal year
ends December 31, 2027
$-1.70—$0
Next quarter
ends December 31, 2026
$-0.37—$0
Quarter after
ends March 31, 2027
$-0.28—$0

Consensus of the analysts covering Nuvectis Pharma, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Nuvectis Pharma stock price target?

The average 12-month target from 5 analysts is $35.40, 74.9% above the current price of $20.24 Targets range from $30.00 to $40.00.

Is Nuvectis Pharma a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Nuvectis Pharma expected to earn?

Analysts expect EPS of $-2.03 for the fiscal year ending December 31, 2026 and $-1.70 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.